- AdventHealth
Rajendra Sawh-Martinez, MD, MHS, FACS
Chief of Pediatric Plastic Surgery
Medical Director of Craniomaxillofacial Surgery
AdventHealth Orlando
Katelyn Lewis, BS
Med Student
University of Central Florida College of Medicine
The Challenge:
We met the male patient on DOL 0, shortly after birth, after his transfer to AdventHealth Orlando with a large, critical skull defect with exposed dura and sagittal sinus. The patient was in critical condition, intubated with bilateral chest tubes placed for bilateral pneumothorax.
The cranial defect was immediately addressed given the life-threatening nature of the defect and was noted clinically to be a full thickness Aplasia Cutis Congenita defect. Critical care was administered by the NbICU team and included multimodal cardiopulmonary resuscitation and thorough evaluation by multiple different medical specialties. The patient would go on to have multidisciplinary team evaluation, including genetic testing which would reveal a diagnosis of Finlay-Marks Syndrome, a rare congenital defect with only 36 previously known cases in the world literature.
Given the situation and the critical size, traditional treatments for the calvarial defect were not deemed adequate. Large scalp flaps or skin grafting would be options but would potentially compromise bony ingrowth. Our team sought new approaches.
The Solution:
We ensured that the scalp was kept in a moist and covered environment. Placentally-derived and layered wound care coverage approaches were undertaken. Both beside procedures and operative intervention were carried out to ensure both early intervention and thorough, sterile debridement and defect management with layered wound coverage.
The patient continued to have multiple reconstructive procedures to improve new epithelization of his scalp. At approximately four weeks after the primary operation, adequate wound healing was appreciated with coverage of critical structures including the dura and sagittal sinus.
The Results:
Now 26 months after treatment, coverage of the skull defect and invaginating bony ingrowth are occurring. The bony defect continues to improve and appears to be getting smaller by novel bony ingrowth which would have thought to be impossible.
The child remains in stable condition and has multiple planned interventions including scalp expansion and possible calvarial grafting if bony in growth is incomplete or inadequate.
Scalp-Ear-Nipple Syndrome, or Finlay-Marks Syndrome, is an extraordinarily rare syndrome characterized by abnormalities of the scalp, ears, and nipples. This syndrome was first reported by Finlay and Marks [1978] who described a family in Cardiff, United Kingdom with ten individuals across five different generations presenting with similar symptomatology of scalp nodules, ear anomalies, and rudimentary nipples (Marks, 1978). Two notable genetic associations with SEN Syndrome are a missense mutation in the KCTD1 gene and a homozygous deficiency of Lef-1 (lymphoid enhancer factor-1) (Morales-Peralts et al., 2014).
Our patient was found to have the KCTD1 mutation. An additional karyotype analysis demonstrated a genotype of 47 XXY, confirming diagnosis of Klinefelter Syndrome.
This patient has an impressive and rare clinical presentation in vastly unknown territory in terms of optimal approaches in a child whose life was compromised. The child’s progress and turnaround are a testament to the expertise, care and attention provided by AdventHealth’s Newborn Intensive Care Unit (NbICU) and pediatric specialists along with the patient’s incredibly dedicated, thoughtful, and loving family. The patient’s recovery and progress are a testament to modern medical treatment and discoveries.
If you have any questions or would like more information, please email Raj.Sawh-Martinez@AdventHealth.com
Recent News
Kidney-tumor patients have an innovative new treatment option, first performed recently by a surgical team at AdventHealth Celebration.
A genetic test, originally conducted to help better understand her daughter's diagnosis, revealed Samantha Arceneaux carries a genetic variant that virtually guarantees she will develop an aggressive...
Under the leadership of investigator Guru Sonpavde, MD, AdventHealth’s Clinical Research Unit (CRU), a collaborative between the AdventHealth Cancer Institute and AdventHealth Research Institute, is...
The AdventHealth Research Institute recently launched two new clinical studies to better understand and address the needs of healthcare employees who work night shifts.
The CheckMate 901 Phase III clinical trial results, recently published in the New England Journal of Medicine, found that combining the programmed death 1 (PD1) inhibitor immunotherapy nivolumab with...
The new SMILE with Stella Tremonti Down Syndrome Clinic is the only lifespan program of its kind in the Southeast.
The accreditation recognizes the hospital’s commitment to excellence in patient care and safety.
After over a decade of not being able to keep food down because of her condition, Rene Galloway has a new lease on life thanks to an AdventHealth interventional endoscopist who saw a chance to help...
AdventHealth broke ground today on AdventHealth Minneola, an 80-bed hospital that will bring inpatient care to the growing population of south Lake County.
“Artificial intelligence is now providing tools that allow us to be more efficient and effective when taking care of patients and we can do it in a way that is safer,” says Dr. Victor Herrera, senior...
AdventHealth University and the soon-to-open Orlando College of Osteopathic Medicine announce a partnership that will keep more physicians in our community.
Life happens and sometimes that means a trip to the emergency room. When it does, AdventHealth’s number one emergency care team is here for you.